- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01167790
Autofluorescence for the Screening of Precancerous and Malignant Lesions (FLUOK)
Interest of Oral Tissue Autofluorescence for the Screening of Precancerous Lesions and Cancer in Population With Tobacco and Alcohol Abuse.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The study of Sankaranarayanan and al. (Lancet on 2005, 4, 1927-1933) demonstrated the influence on the decline of mortality of a realized systematic screening, by a simple visual inspection of the oral cavity in alcohol-smoker patients. The sensibility of the visual inspection to diagnose the oral cancers is estimated at 85 % and the specificity in 97 %. However some lésions are not diagnosed with common oral examination(Downer MC Oral Oncol. 2004 ( 3 ) 264-73). The examination in autofluorescence coupled with the visual inspection could be a solution to improve early diagnosis of potentially malignant disorders . Indeed, dysplasia and cancerous lesions can be revealing by an autofluorescence examination (Lane PM J Biomed opt on 2006 ( 2 ): 024006). Other works demonstrated that infra-clinical lesions could be revealed by the autofluorescence (Poh CF Wink Cancer Res on 2006 ( 22 ): 6616-22; Poh CF Head Neck 2007 ( 1 ) 7 71-6). On the other hand the sensibility and the specificity of the autofluorescence in situation of screening were not estimated and studies carried out on sick subjects tend to overestimate the metrological performances of a technique. Besides the reliability of the technique (reproducibility) was not studied. For these reasons, it is recommended to realize in situation of screening in an alcohol-smoker population:
- a study of reliability to estimate the reproducibility inter-observer of the examination of the oral cavity in tissular autofluorescence and,
- a feasibility study to estimate the potential contribution of the autofluorescence with regard to a simple visual inspection in the screening of the potential malignant disorders.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Bordeaux, France, 33000
- Hopital Saint André
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- patients hospitalized for alcoholic weaning
- consumption activates of tobacco or stop for less than one year
- consent form signed
Exclusion Criteria:
- patient presenting a disorder of the haemostasis (plaques < 50G / L; INR > 3, haemophilia, moderate or severe Willebrand disease),
- absorption of acid acetylsalicylic in seven days before inclusion,
- the patient with oral cavity precancerous pathology, dysplasia or known cancer patient
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
reliability
Time Frame: one day
|
Concordance inter-observer, considered by the coefficient kappa of Cohen, towards the decision to make a biopsy of a suspicious lesion(potentially malignant lesions, dysplasia and cancer)
|
one day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Prevalence
Time Frame: one day
|
Prevalence of potentially malignant lesions, dysplasia and cancer patient of the oral cavity in conditions of screening in an alcoolo-smoking population.
|
one day
|
Validity
Time Frame: one day
|
anatomopathologic diagnosis wil be compared to examination in both techniques of examination
|
one day
|
safety
Time Frame: one day
|
adverse events of the procedure (biopsy)
|
one day
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jean-chritophe FRICAIN, Md-PhD, University Hospital, Bordeaux
- Study Chair: Adélaïde DOUSSAU, MD, University Hospital, Bordeaux
- Study Director: Jean-christophe FRICAIN, MD-PhD, University Hospital, Bordeaux
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- CHUBX 2010/02
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Precancerous Lesions of the Oral Mucosa
-
University of California, IrvineBeckman Laser Institute University of California IrvineCompletedOther Lesions of Oral MucosaUnited States
-
Centre Hospitalier Universitaire DijonCompletedCancerous Lesions of the Oral CavityFrance
-
Azienda Socio Sanitaria Territoriale degli Spedali...RecruitingOral Premalignant LesionsItaly
-
Cairo UniversityCompletedOral Premalignant LesionsEgypt
-
Tomasz RomańczykCompletedHeterotopic Gastric Mucosa of the Proximal EsophagusPoland
-
Eisai Inc.Eisai LimitedCompletedLesions of the LiverJapan
-
Peking University Third HospitalCompletedOsteochondral Lesions of the Talus
-
Ministry of Health, KuwaitNot yet recruitingOsteochondral Lesions of the Talus
-
University Hospital, Strasbourg, FranceNot yet recruitingLesions of the Anal SphincterFrance
-
Saint Thomas Hospital, PanamaCompletedLSIL, Low-Grade Squamous Intraepithelial LesionsPanama
Clinical Trials on buccal cavity examination
-
Datar Cancer Genetics LimitedNational University of Singapore; Test At Home Pte. LtdNot yet recruiting
-
Centre Hospitalier Universitaire de NiceCompleted
-
The Hashemite UniversityCompletedSleep | Anxiety Depression | Memory DisordersJordan
-
University of EdinburghNHS Lothian; Department of Health, United KingdomUnknown
-
University of MinnesotaBaylor College of Medicine; University of California, San Diego; New York University and other collaboratorsTerminatedUrethral StrictureUnited States
-
University of California, San FranciscoBaylor College of Medicine; University of California, San Diego; New York University and other collaboratorsTerminatedUrethral StrictureUnited States
-
Universitaire Ziekenhuizen KU LeuvenKU LeuvenUnknownDNA MethylationBelgium
-
Northwestern UniversityViraCor LaboratoriesCompletedAtopic Dermatitis | Ichthyosis VulgarisUnited States
-
Tanta UniversityRecruitingOro-Antral CommunicationEgypt